A brief overview of our top stories.
Hello and welcome to Contagion. Recent concerns have been raised about a spike protein mutation in SARS-CoV-2. In a new, joint interview, we ask coronavirus experts about the developing story. According to virologist Dr. Jason Kindrachuk, it’s worth making sure we don’t jump to conclusions based on preliminary information.
In other news, Janssen Pharmaceutical Companies, a part of Johnson & Johnson, has announced that the European Commission has granted Marketing Authorization for its 2-dose Ebola vaccine regimen.
Janssen will collaborate with the World Health Organization on vaccine pre-qualification, in order to hasten registration in endemic countries and facilitate broader access.
And lastly, Employers are looking for guidance when it comes to COVID-19. We talked to Dr. Jonathan Spero, who has been involved in establishing point-of-production medical practices and clinics since before the pandemic.
For these stories, and the latest infectious disease news, visit Contagionlive.com. Thanks for tuning in.
